Latest News on Drug Price Control Order
Showing of 0 - 10 from 9 results
Drug Price Control Order - Total results - 9
Sep 27, 2017
Abbott's decision to pull out Xience Alpine stent won't impact Indian patients, claim health activistsAbbott recently got the approval to withdraw Xience Alpine stent from India by the NPPA, however, health activists believe the move would benefit Indian high-end medical device makers
Apr 27, 2017
Medical stent regulation row: Govt's move to prohibit companies from withdrawing stents is wrongOver the last few months, the National Pharmaceutical Pricing Authority (NPPA) has been in a tussle with manufacturers of cardiac stents.
Jul 15, 2015
SC terms drugs policy 'unreasonable', asks Centre to re-lookThe court was hearing a PIL filed by NGO All India Drug Action Network alleging that the MBP was never used for any price regulatory purposes and this was making medicines costlier.
Oct 27, 2014
De-controlling drug prices: SC refuses to interfere in Centre's decisionThe Supreme Court today refused to interfere with the Centre's decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation.
Aug 23, 2014
Drug price debate; Don't cow down to pharma pressure, activists tell govtCountering the industry’s claims that the decontrol of prices will cause an annual loss of revenues of over Rs.600 crores, activists note that NPPA’s action on the market will be marginal. It will affect only those brands that were selling at very high prices.
Jul 16, 2014
Healthcare: How govt can make essential drugs affordableThe regulator, NPPA, has said that even among generics there is considerable price variability which indicates market failure. It’s only natural that the government intervenes when the market mechanism fails in checking prices.
Oct 03, 2013
SC raises ceiling price question on new Drug price Control OrderThe Supreme Court today raised a question on the new Drug Price Control Order (DPCO) of the Centre to fix the ceiling price of essential medicines on the basis of market-based pricing
May 17, 2013
Why the new drug price controls won't impact most consumersWhat the new pricing policy does is that it replaces the earlier regime, in which prices of drugs were calculated based on the cost of manufacture, with a regime that decides the prices based on existing market prices of top selling brands. The new regime takes the average of the three brands that have one percent of the market share.
May 16, 2013
Good news: Soon, anti-cancer drug prices to fall by 80%Prices of 348 medicines, including life saving drugs will be cheaper soon by up to 80 percent as the new Drug Price Control Order has come into effect.